Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Universal ambitions

How Emergex aims to create universal vaccines for viral epidemics

Alicia Parker, Staff Writer
May 25, 2018 7:54 PM UTC

Emergex Vaccines Holdings Ltd. is making synthetic peptide vaccines it thinks could provide universal immunity -- and at a fraction of the time and cost of traditional vaccine development.

Emergex launched in 2016 with IP acquired from Immunotope Inc. covering the discovery of viral peptides that are immunogenic and highly conserved between members of a genus...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Emergex Vaccines Holdings Ltd.